| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $15,625,000 | 1 | 17 |
Sells | $506,730 | 5 | 83 |
| PAULSON & CO. INC. | 10 percent owner | 1 | $15.63M | 0 | $0 | $15.63M |
| Carson Seana | EVP, General Counsel | 0 | $0 | 3 | $115,040 | $-115,040 |
| Lee Frank D. | director | 0 | $0 | 1 | $132,796 | $-132,796 |
| Lenar Aimee J. | President, US Pharma | 0 | $0 | 1 | $258,894 | $-258,894 |
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, …
Over the last 12 months, insiders at Bausch Health Companies Inc. have bought $15.63M and sold $506,730 worth of Bausch Health Companies Inc. stock.
On average, over the past 5 years, insiders at Bausch Health Companies Inc. have bought $128.9M and sold $357,879 worth of stock each year.
Highest buying activity among insiders over the last 12 months: PAULSON & CO. INC. (10 percent owner) — $15.63M.
The last purchase of 2,500,000 shares for transaction amount of $15.63M was made by PAULSON & CO. INC. (10 percent owner) on 2025‑11‑25.
| 2026-08-19 | Sale | Lenar Aimee J. | President, US Pharma | 36,827 0.01% | $7.03 | $258,894 | -8.56% | |
| 2026-05-19 | Sale | Lee Frank D. | director | 24,456 0.0067% | $5.43 | $132,796 | +8.74% | |
| 2026-03-03 | Sale | Carson Seana | EVP, General Counsel | 4,420 0.0012% | $5.77 | $25,503 | -2.01% | |
| 2026-03-02 | Sale | Carson Seana | EVP, General Counsel | 6,856 0.0018% | $5.78 | $39,628 | -5.38% | |
| 2026-02-27 | Sale | Carson Seana | EVP, General Counsel | 8,388 0.0023% | $5.95 | $49,909 | -5.06% | |
| 2025-11-25 | PAULSON & CO. INC. | 10 percent owner | 2.5M 0.6994% | $6.25 | $15.63M | -8.70% | ||
| 2025-09-08 | Sale | Carson Seana | EVP, General Counsel | 13,370 0.0036% | $7.31 | $97,735 | -18.01% | |
| 2025-08-21 | Sale | Lee Frank D. | director | 15,912 0.0044% | $7.66 | $121,886 | -19.87% | |
| 2025-08-14 | Paulson John | director | 34.72M 11.2523% | $9.00 | $312.49M | -19.97% | ||
| 2025-08-13 | Paulson John | director | 86,409 0.023% | $7.06 | $610,048 | -16.18% | ||
| 2025-08-12 | Paulson John | director | 1.16M 0.3231% | $6.88 | $7.96M | -14.14% | ||
| 2025-08-11 | Paulson John | director | 2M 0.5157% | $6.35 | $12.7M | -9.76% | ||
| 2025-06-13 | Paulson John | director | 3.56M 0.958% | $5.94 | $21.17M | +3.60% | ||
| 2025-06-12 | Paulson John | director | 1.01M 0.2701% | $5.47 | $5.5M | +12.34% | ||
| 2025-06-11 | Paulson John | director | 1.03M 0.2738% | $5.24 | $5.39M | +16.14% | ||
| 2025-06-10 | Paulson John | director | 754,134 0.2021% | $5.05 | $3.81M | +21.37% | ||
| 2024-12-02 | Sale | Carson Seana | EVP, General Counsel | 440 0.0001% | $8.35 | $3,674 | -15.35% | |
| 2024-09-06 | Sale | Carson Seana | EVP, General Counsel | 13,370 0.0036% | $6.21 | $83,028 | +15.14% | |
| 2024-03-04 | Sale | Carson Seana | EVP, General Counsel | 6,313 0.0018% | $9.80 | $61,867 | -20.67% | |
| 2023-12-05 | Sale | Carson Seana | EVP, General Counsel | 220 <0.0001% | $7.38 | $1,624 | +12.55% |
| PAULSON & CO. INC. | 10 percent owner | 73255869 19.5732% | $596.3M | 1 | 0 | |
| Paulson John | director | 70755869 18.9052% | $575.95M | 13 | 2 | +11.57% |
| ValueAct Holdings, L.P. | director | 17931594 4.7911% | $145.96M | 19 | 3 | +19.98% |
| Pearson J. Michael | Chief Executive Officer | 1514664 0.4047% | $12.33M | 2 | 1 | +18.52% |
| Morfit G Mason | See Remarks | 1352941 0.3615% | $11.01M | 1 | 0 | +30.3% |
| UBBEN JEFFREY W | director | 1059793 0.2832% | $8.63M | 3 | 1 | +44.4% |
| PAPA JOSEPH C | CHAIRMAN & CEO | 839601 0.2243% | $6.83M | 5 | 0 | +0.47% |
| Rosiello Robert L. | EVP, Chief Financial Officer | 441675 0.118% | $3.6M | 3 | 0 | <0.0001% |
| DE SCHUTTER RICHARD U | director | 317109 0.0847% | $2.58M | 10 | 0 | +15.65% |
| DE SILVA RAJIV | President and COO | 265217 0.0709% | $2.16M | 1 | 3 | +16.48% |
| Humphries William D. | President, Ortho-Dermatologics | 235035 0.0628% | $1.91M | 1 | 5 | <0.0001% |
| Herendeen Paul | EVP and CFO | 216866 0.0579% | $1.77M | 3 | 0 | +27.32% |
| Schiller Howard Bradley | Chairman and CEO | 182900 0.0489% | $1.49M | 8 | 0 | +11.49% |
| ACKERMANN CHRISTINA | EVP AND GENERAL COUNSEL | 166758 0.0446% | $1.36M | 1 | 5 | <0.0001% |
| Loberg Philip Walden Jr | EVP, Interim CFO | 137565 0.0368% | $1.12M | 1 | 0 | <0.0001% |
| Provencio Norma Ann | director | 137495 0.0367% | $1.12M | 6 | 8 | +18.22% |
| APPIO THOMAS | Pres&Co-Head Bausch&Lomb/Int'l | 128922 0.0344% | $1.05M | 1 | 0 | +3.24% |
| Ross Thomas W. Sr. | director | 79242 0.0212% | $645,029.88 | 3 | 0 | <0.0001% |
| PAUL LAURENCE E | director | 60459 0.0162% | $492,136.26 | 5 | 0 | +19.25% |
| Miller Steven D | director | 60780 0.0162% | $494,749.20 | 1 | 0 | <0.0001% |
| Hassan Fred | director | 53969 0.0144% | $439,307.66 | 1 | 0 | +22.43% |
| Kornwasser Laizer | EVP, Company Group Chairman | 53582 0.0143% | $436,157.48 | 6 | 0 | +16.39% |
| Chai-Onn Robert Roswell | EVP, CLO, General Counsel | 43187 0.0115% | $351,542.18 | 2 | 6 | +7.18% |
| VON ESCHENBACH ANDREW C. | director | 38647 0.0103% | $314,586.58 | 2 | 0 | <0.0001% |
| Stolz Brian M. | EVP, Administration & CHCO | 32156 0.0086% | $261,749.84 | 7 | 0 | +19.31% |
| STEVENSON KATHARINE BERGHUIS | director | 23098 0.0062% | $188,017.72 | 4 | 0 | +35.79% |
| Segal Lloyd Mitchell | director | 21174 0.0057% | $172,356.36 | 5 | 0 | +36.29% |
| KARABELAS ARGERIS N | director | 20726 0.0055% | $168,709.64 | 1 | 0 | <0.0001% |
| Farmer Ronald Harold | director | 15532 0.0041% | $126,430.48 | 15 | 0 | <0.0001% |
| Whitaker Anne Clem | director | 7500 0.002% | $61,050.00 | 1 | 0 | <0.0001% |
Bausch Health Companies Inc. (BHC) | $1,279,728,023 | 131 | 10.76% | $3.05B |
$25,613,591 | 65 | -3.30% | $12.27B | |
$14,599,168 | 59 | 12.79% | $1.66B | |
$102,709,455 | 46 | 30.55% | $1.45B | |
$73,762,556 | 45 | -9.99% | $2.17B |
| Increased Positions | 141 | +63.8% | 30M | +12.63% |
| Decreased Positions | 86 | -38.91% | 35M | -14.69% |
| New Positions | 53 | New | 6M | New |
| Sold Out Positions | 33 | Sold Out | 8M | Sold Out |
| Total Postitions | 276 | +24.89% | 236M | -2.06% |
| Paulson & Co. Inc. | $510,150.00 | 19.07% | 70.76M | +38M | +115.77% | 2025-09-30 |
| Goldentree Asset Management Lp | $251,149.00 | 9.39% | 34.83M | +578,542 | +1.69% | 2025-09-30 |
| Nomura Holdings Inc | $113,255.00 | 4.23% | 15.71M | -6M | -26.92% | 2025-09-30 |
| Healthcare Of Ontario Pension Plan Trust Fund | $93,730.00 | 3.5% | 13M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $88,258.00 | 3.3% | 12.24M | -796,319 | -6.11% | 2025-09-30 |
| Royal Bank Of Canada | $75,752.00 | 2.83% | 10.51M | +1M | +12.39% | 2025-09-30 |
| National Bank Of Canada /Fi/ | $55,683.00 | 2.08% | 7.72M | -16,550 | -0.21% | 2025-09-30 |
| Mfn Partners Management, Lp | $43,260.00 | 1.62% | 6M | 0 | 0% | 2025-09-30 |
| Kohlberg Kravis Roberts & Co. L.P. | $37,744.00 | 1.41% | 5.24M | 0 | 0% | 2025-09-30 |
| Ubs Group Ag | $37,120.00 | 1.39% | 5.15M | +4M | +397.78% | 2025-09-30 |